Clinical Trials Browser

Phase 1/2 × Thiotepa × 90 days × Clear all

NCT06158828 2026-05-05

ABCD-NK

Phase 1/2 Recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT04990323 2026-03-24

US Study of ECT-001-CB in Pediatric and Young Adult Patients With High-Risk Myeloid Malignancies

Phase 1/2 Completed

High Risk Myeloid Malignancies